Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Hims, Amazon
Amazon's push into telehealth knocks shares of Hims & Hers
Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits.
Hims & Hers drops 17% as Amazon rolls out expanded telehealth service
Shares of telehealth services provider Hims & Hers (NYSE:HIMS) fell 17% in morning trading Thursday after Amazon (NASDAQ:AMZN) announced it was launching an expanded pay-per-visit telehealth service,
Hims & Hers Stock Drops After Amazon Says It Will Offer Hair-Loss Treatments
Shares of Hims & Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and erectile dysfunction, directly competing with the telehealth startup. Amazon on Thursday launched the treatments through its One Medical telehealth service,
Hold Rating for Hims & Hers Health Amidst Competitive Pressure from Amazon’s Telehealth Services
Citi analyst Daniel Grosslight has maintained their neutral stance on HIMS stock, giving a Hold rating on November 6. Daniel
Hims & Hers’ stock tumbles on Amazon’s latest disruptive foray into healthcare
Hims & Hers Health Inc. shares tumbled 22% Thursday, on concerns that Amazon.com Inc.’s latest push into healthcare will disrupt Hims & Hers’ business. Amazon One Medical launched a new service Thursday that offers upfront pricing for telehealth visits for a range of issues and ailments — including men’s hair loss,
Amazon Gets Into the Boner Pill Business, Hims Stock Goes Limp
The pricing will show up at checkout when users are logged into Amazon with a Prime membership. Amazon acquired primary care provider One Medical for $3.9 billion in 2022, and fills prescriptions through Amazon Pharmacy.
Hims & Hers stock falls as Amazon launches Telehealth offering
Shares of Hims & Hers Health, Inc. (HIMS) dropped over 15% Thursday following Amazon’s announcement of new telehealth treatment options aimed at providing low-cost care for a range of health and beauty concerns,
14h
on MSN
Amazon’s telehealth platform adds low-cost plans for hair loss, skin care, and more
Amazon One Medical is expanding its telehealth services with the launch of treatment plans and medication delivery for ...
10h
on MSN
Amazon Will Start Selling Cheap Hair-Loss Drugs. It’s a Huge Threat for This Stock.
The tech company’s prices appear set to undercut the long list of competing telehealth companies that rely on aggressive ...
STAT
14h
A telehealth friend in the new Congress, and Amazon’s smile on a mental health service
Today, details about
Amazon
’s new mental health partner ... so too do the prospects for important
telehealth
policy. But ...
Fierce Healthcare
17h
Amazon One Medical rolls out telehealth treatment services in competition with Ro, Hims & Hers
Amazon One Medical is rolling out a new service to provide Prime members access to clinical treatments for common health and ...
Yahoo
12h
Amazon is getting into the erectile dysfunction business
Amazon
(AMZN) has been steadily expanding into healthcare, and now it’s setting its sights on
telehealth
companies like ...
11h
Hims & Hers drops 22% on Amazon competition concerns (update)
Hims & Hers (HIMS) fell 22% after Amazon (AMZN) announced it was entering the hair loss and erectile dysfunction treatment ...
11h
Amazon.com introduces Amazon One Medical Pay-per-visit telehealth service
Amazon says that Prime members can now quickly and easily treat health, beauty, and lifestyle conditions for as low as $16/month for ...
NBC Chicago
2d
Amazon shuts down secret project to develop fertility tracker
Other Grand Challenge projects, like the
Amazon
Care
telehealth
service, a video-calling device for kids, a virtual tours ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback